FNDC5 could be regulated by leptin in adipose tissue

European Journal of Clinical Investigation

Volumn 44, Issue 10, 2014, Pages 918-925

  Gutierrez Repiso, Carolina ^a   Garcia Serrano, Sara ^a,b   Rodriguez Pacheco, Francisca ^a   Garcia Escobar, Eva ^a,b   Haro Mora, Juan J ^a   Garcia Arnes, Juan ^a   Valdes, Sergio ^a,b   Gonzalo, Montserrat ^a   Soriguer, Federico ^a,b   Moreno Ruiz, Francisco J ^a   Rodriguez Cañete, Alberto ^a   Martinez Ferriz, Abelardo ^a   Santoyo, Julio S ^a   Perez Valero, Vidal ^a   Garcia Fuentes, Eduardo ^a,b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adipose tissue; FNDC5; Irisin; Leptin; Morbid obesity; PCG1 ; Waist to hip ratio

Indexed keywords

FIBRONECTIN; FNDC5 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LEPTIN; MESSENGER RNA;

ADULT; BLOOD; CHEMISTRY; DOWN REGULATION; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLISM; MORBID OBESITY; PHYSIOLOGY; SUBCUTANEOUS FAT; WAIST HIP RATIO;

ADULT; DOWN-REGULATION; FEMALE; FIBRONECTINS; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; INTRA-ABDOMINAL FAT; LEPTIN; MALE; OBESITY, MORBID; RNA, MESSENGER; SUBCUTANEOUS FAT; WAIST-HIP RATIO;

EID: 84908687480     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12324     Document Type: Article

References (33)

1. World Health Organization. Waist Circumference and Waist-hip Ratio. Report of a WHO Expert Consultation. Generve: WHO; 2011.
2. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P et al. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-9.
3. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk-a review of the literature. Eur J Clin Nutr 2010;64:16-22.
4. Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev 2011;12:680-7.
5. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005;1:361-70.
6. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A 2009;106:20405-10.
7. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463-8.
8. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012;61:1725-38.
9. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013;98:E769-78.
10. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belén Crujeiras A et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE 2013;8:e60563.
11. Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013;27:365-9.
12. Sanchis-Gomar F, Perez-Quilis C. Irisinemia: a novel concept to coin in clinical medicine? Ann Nutr Metab 2013;63:60-1.
13. García-Fuentes E, García-Almeida JM, García-Arnés J, García-Serrano S, Rivas-Marín J, Gallego-Perales JL et al. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring) 2007;15:2391-5.
14. Garrido-Sánchez L, García-Almeida JM, García-Serrano S, Cardona I, García-Arnes J, Soriguer F et al. Improved carbohydrate metabolism after bariatric surgery raises antioxidized LDL antibody levels in morbidly obese patients. Diabetes Care 2008;31:2258-64.
15. Tinahones FJ, Garrido-Sanchez L, Miranda M, García-Almeida JM, Macias-Gonzalez M, Ceperuelo V et al. Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes Surg 2010;20:1559-67.
16. Tinahones FJ, Murri-Pierri M, Garrido-Sánchez L, García-Almeida JM, García-Serrano S, García-Arnés J et al. Oxidative stress in severely obese persons is greater in those with insulin resistance. Obesity (Silver Spring) 2009;17:240-6.
17. Garcia-Fuentes E, Garrido-Sanchez L, Garcia-Almeida JM, Garcia-Arnes J, Gallego-Perales JL, Rivas-Marin J et al. Different effect of laparoscopic Roux-en-Y gastric bypass and open biliopancreatic diversion of Scopinaro on serum PYY and ghrelin levels. Obes Surg 2008;18:1424-9.
18. Garrido-Sanchez L, Murri M, Rivas-Becerra J, Ocaña-Wilhelmi L, Cohen RV, Garcia-Fuentes E et al. Bypass of the duodenum improves insulin resistance much more rapidly than sleeve gastrectomy. Surg Obes Relat Dis 2012;8:145-50.
19. Spanish Society for the Study of Obesity. [1995 Spanish consensus for the evaluation of obesity and to carry out epidemiologic studies]. Med Clin (Barc) 1996;107:782-7.
20. Garrido-Sanchez L, Escote X, Coin-Aragüez L, Fernandez-Garcia JC, El Bekay R, Vendrell J et al. Munc18c in adipose tissue is downregulated in obesity and is associated with insulin. PLoS ONE 2013;8:e63937.
21. Gutierrez-Repiso C, Velasco I, Garcia-Escobar E, Garcia-Serrano S, Rodriguez-Pacheco F, Linares F et al. Does dietary iodine regulate oxidative stress and adiponectin levels in human breast milk? Antioxid Redox Signal 2014;20:847-53.
22. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013;39:125-30.
23. Zalesin KC, Franklin BA, Lillystone MA, Shamoun T, Krause KR, Chengelis DL et al. Differential loss of fat and lean mass in the morbidly obese after bariatric surgery. Metab Syndr Relat Disord 2010;8:15-20.
24. Pereira AZ, Marchini JS, Carneiro G, Arasaki CH, Zanella MT. Lean and fat mass loss in obese patients before and after Roux-en-Y gastric bypass: a new application for ultrasound technique. Obes Surg 2012;22:597-601.
25. Enriori PJ, Evans AE, Sinnayah P, Jobst EE, Tonelli-Lemos L, Billes SK et al. Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons. Cell Metab 2007;5:181-94.
26. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
27. Després JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012;126:1301-13.
28. Seidell JC. Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea. Eur J Clin Nutr 2010;64:35-41.
29. Yasari S, Wang D, Prud'homme D, Jankowski M, Gutkowska J, Lavoie JM. Exercise training decreases plasma leptin levels and the expression of hepatic leptin receptor-a, -b, and, -e in rats. Mol Cell Biochem 2009;324:13-20.
30. Arya R, Duggirala R, Jenkinson CP, Almasy L, Blangero J, O'Connell P et al. Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans. Am J Hum Genet 2004;74:272-82.
31. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009;360:150915-7.
32. Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010;21:643-51.
33. St-Pierre J, Tremblay ML. Modulation of leptin resistance by protein tyrosine phosphatases. Cell Metab 2012;15:292-7.